Q1 EPS Estimates for Astera Labs Lifted by Northland Capmk

Astera Labs, Inc. (NASDAQ:ALAB) – Northland Capmk boosted their Q1 2025 EPS estimates for shares of Astera Labs in a report issued on Tuesday, February 11th. Northland Capmk analyst G. Richard now anticipates that the company will post earnings per share of $0.06 for the quarter, up from their previous forecast of ($0.01). Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs’ Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.07 EPS, FY2025 earnings at $0.25 EPS and FY2026 earnings at $0.61 EPS.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%.

A number of other brokerages have also recently weighed in on ALAB. Stifel Nicolaus lifted their price target on shares of Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Craig Hallum increased their price target on Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a research note on Tuesday, January 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $140.00 target price on shares of Astera Labs in a research report on Tuesday, February 11th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Buy” and a consensus target price of $115.33.

Astera Labs Stock Performance

ALAB stock opened at $87.85 on Friday. The business has a fifty day simple moving average of $120.17 and a 200-day simple moving average of $83.22. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently added to or reduced their stakes in ALAB. Voleon Capital Management LP bought a new position in shares of Astera Labs during the fourth quarter worth about $4,700,000. Utah Retirement Systems bought a new stake in Astera Labs in the 4th quarter valued at about $768,000. Emerald Mutual Fund Advisers Trust boosted its stake in Astera Labs by 429.3% during the 4th quarter. Emerald Mutual Fund Advisers Trust now owns 704 shares of the company’s stock valued at $93,000 after purchasing an additional 571 shares during the period. Lido Advisors LLC grew its position in Astera Labs by 74.6% in the 4th quarter. Lido Advisors LLC now owns 14,012 shares of the company’s stock worth $1,856,000 after purchasing an additional 5,986 shares during the last quarter. Finally, Northern Trust Corp increased its stake in shares of Astera Labs by 257.7% in the fourth quarter. Northern Trust Corp now owns 296,120 shares of the company’s stock valued at $39,221,000 after purchasing an additional 213,343 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Stefan A. Dyckerhoff sold 197,297 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $90.51, for a total value of $17,857,351.47. Following the sale, the director now owns 6,148 shares of the company’s stock, valued at approximately $556,455.48. This trade represents a 96.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Michael Truett Tate sold 16,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.84, for a total value of $1,885,440.00. Following the transaction, the chief financial officer now owns 1,412,888 shares of the company’s stock, valued at $166,494,721.92. This represents a 1.12 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 846,452 shares of company stock valued at $86,427,256.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.